Feedback control of the arachidonate cascade in osteoblastic cells by 15-deoxy-Δ12,14-prostaglandin J2

被引:2
|
作者
Ishino, Hidetaka [1 ]
Kawahito, Yutaka [1 ]
Tsubouchi, Yasunori [1 ]
Kohno, Masataka [1 ]
Wada, Makoto [1 ]
Yamamoto, Aihiro [1 ]
Hamaguchi, Masahide [1 ]
Kadoya, Masatoshi [1 ]
Tokunaga, Daisaku [1 ]
Hojo, Tatsuya [1 ]
Matsuyama, Masahide [2 ]
Yoshimura, Rikio [2 ]
Yoshikawa, Toshikazu [1 ]
机构
[1] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kyoto 6028566, Japan
[2] Osaka City Univ Hosp, Dept Urol, Osaka 5458585, Japan
关键词
15d-PGJ(2); PPAR-gamma; osteoblast; PGE(2); COX-2;
D O I
10.3164/jcbn.2008011
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) and an anti-diabetic thiazolidinedione, troglitazone (TRO) are peroxisome proliferator-activated receptor (PPAR)-gamma ligands, which regulate immuno-inflammatory reactions as well as adipocyte differentiation. We previously reported that 15d-PGJ(2) can suppress interleukin (IL)-1 beta-induced prostaglandin E-2 (PGE(2)) synthesis in synoviocytes of rheumatoid arthritis (RA). IL-1 also stimulates PGE2 synthesis in osteoblasts by regulation of cyclooxygenase (COX)-2 and regulates osteoclastic bone resorption in various diseases such as RA and osteoporosis. In this study, we investigated the feedback mechanism of the arachidonate cascade in mouse osteoblastic cells, MC3T3-E1 cells, which differentiate into mature osteoblasts. Treatment with 15d-PGJ(2) led to a significant increase in IL-1 alpha-induced COX-2 expression and PGE2 production in a dose dependent manner. The effect of 15d-PGJ(2) was stronger than that of TRO. However, it did not affect the expression of COX-1. In addition, cell viability of MC3T3-E1 cells was not changed in the condition we established. This means that 15d-PGJ(2) exerts a positive feedback regulation of the arachidonate cascade of PGE(2) in osteoblastic cells. These results may provide important information about the pathogenesis and treatment of bone resorption in a variety of diseases such as RA and osteoporosis.
引用
收藏
页码:64 / 69
页数:6
相关论文
共 50 条
  • [21] 15-Deoxy-Δ12,14-prostaglandin J2 inhibits CX3CL1/fractalkine expression in human endothelial cells
    Imaizumi, T
    Matsumiya, T
    Tamo, W
    Shibata, T
    Fujimoto, K
    Kumagai, M
    Yoshida, H
    Cui, XF
    Tanji, K
    Hatakeyama, M
    Wakabayashi, K
    Satoh, K
    IMMUNOLOGY AND CELL BIOLOGY, 2002, 80 (06) : 531 - 536
  • [22] 15-Deoxy-Δ12,14-Prostaglandin J2 Biphasically Regulates the Proliferation of Mouse Hippocampal Neural Progenitor Cells by Modulating the Redox State
    Katura, Takashi
    Moriya, Takahiro
    Nakahata, Norimichi
    MOLECULAR PHARMACOLOGY, 2010, 77 (04) : 601 - 611
  • [23] 15-Deoxy-Δ12,14-prostaglandin J2 inhibits HIV-1 transactivating protein, Tat, through covalent modification
    Kalantari, Parisa
    Narayan, Vivek
    Henderson, Andrew J.
    Prabhu, K. Sandeep
    FASEB JOURNAL, 2009, 23 (08) : 2366 - 2373
  • [24] 15-Deoxy-Δ12,14-prostaglandin J2, an electrophilic lipid mediator of anti-inflammatory and pro-resolving signaling
    Surh, Young-Joon
    Na, Hye-Kyung
    Park, Jong-Min
    Lee, Ha-Na
    Kim, Wonki
    Yoon, In-Soo
    Kim, Dae-Duk
    BIOCHEMICAL PHARMACOLOGY, 2011, 82 (10) : 1335 - 1351
  • [25] 15-Deoxy-Δ-12,14-prostaglandin J2 effects in vascular smooth muscle cells: Implications in vascular smooth muscle cell proliferation and contractility
    Eguez, Carl
    Clark, Michelle A.
    O'Connor, Ann Tenneil
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2021, 156
  • [26] 15-Deoxy-Δ12,14-prostaglandin J2 inhibits migration of human thyroid carcinoma cells by disrupting focal adhesion complex and adherens junction
    Wu, Ya-Chieh
    Jhao, Yun-Ting
    Cheng, Yu-Chen
    Chen, Ying
    ONCOLOGY LETTERS, 2017, 13 (04) : 2569 - 2576
  • [27] Endogenous 15-deoxy-Δ12,14-prostaglandin J2 synthesized by adipocytes during maturation phase contributes to upregulation of fat storage
    Mazid, Md. Abdul
    Asad Chowdhury, Abu
    Nagao, Kohjiro
    Nishimura, Kohji
    Jisaka, Mitsuo
    Nagaya, Tsutomu
    Yokota, Kazushige
    FEBS LETTERS, 2006, 580 (30) : 6885 - 6890
  • [28] 15-Deoxy-Δ12,14-prostaglandin J2 as a potential regulator of bone metabolism via PPARγ-dependent and independent pathways: a review
    Xiong, Zhencheng
    Luo, Pan
    Zhou, Jun
    Tan, Mingsheng
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 1879 - 1888
  • [29] The role of 15-deoxy-Δ12,14-prostaglandin J2, an endogenous ligand of peroxisome proliferator-activated receptor γ, in tumor angiogenesis
    Kim, Eun-Hee
    Surh, Young-Joon
    BIOCHEMICAL PHARMACOLOGY, 2008, 76 (11) : 1544 - 1553
  • [30] Suppression of chondrosarcoma cells by 15-deoxy-Δ 12,14-prostaglandin J2 is associated with altered expression of Bax/Bcl-xL and p21
    Shen, ZN
    Nishida, K
    Doi, H
    Oohashi, T
    Hirohata, S
    Ozaki, T
    Yoshida, A
    Ninomiya, Y
    Inoue, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 328 (02) : 375 - 382